Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

NCT01889420 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Multiple Myeloma in Relapse

Interventions

DRUG: Combination therapy

Sponsor

New Mexico Cancer Research Alliance

Collaborators

[object Object]